PATH-26. A NOVEL PLASMA microRNA SIGNATURE FOR GLIOBLASTOMA DETECTION

BACKGROUND: Glioblastoma (GBM) is the most common and aggressive primary brain tumor having a median overall survival below 15 months. To improve the prognosis, biomarkers are needed for early detection of GBM progression. In the present study we identified differentially expressed microRNAs (miRNAs...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Feddersen, Søren, Hermansen, Simon Kjær, Burton, Mark, Sørensen, Mia, Rasmussen, Lars Melholt, Kristensen, Bjarne Winther
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692882/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.716
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items